The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design

Background: Despite rapid advances in research on Parkinson's disease (PD), in particular in the elucidation of genetic contributions, no disease-modifying therapy has become available to date. Objectives: In the proposed project, we aim to investigate the potential effects of vitamin K2 (long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasuhn, Jannik, Kasten, Meike, Vos, Melissa, König, Inke R., Schmid, Sebastian M., Wilms, Britta, Klein, Christine, Brüggemann, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829299/
https://www.ncbi.nlm.nih.gov/pubmed/33505346
http://dx.doi.org/10.3389/fneur.2020.592104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829299/
https://www.ncbi.nlm.nih.gov/pubmed/33505346
http://dx.doi.org/10.3389/fneur.2020.592104

Ejemplares similares